As of Oct 26, 2026: Gilbert Lynn Marks (Director, ANTX) reported no shares bought or sold themselves in the last 12 months (Form 4). ANTX's Quality Score is -2. Scores as of 11:11 PM ET, 15 minutes behind.

Gilbert Lynn Marks

Director of AN2 Therapeutics

No shares they bought or sold themselves in the last 12 months. Their newest Form 4, for Oct 12: stock award (2,283 ANTX shares).

Bought$012 months Sold$012 months Last filedOct 12stock award

From SEC Form 4s · Insiders have 2 business days to file a trade

Every trade Gilbert Lynn Marks reported

None in the last 12 months, as filed.

2 other filings (stock awards) and the shares Gilbert Lynn Marks holds, for Pro members. See them free →

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See ANTX's 14 chart checksSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Gilbert Lynn Marks' companies

Where they file, with the stock's Quality Score

Company	Title, as filed	Trades	Quality Score
ANTXAN2 TherapeuticsDirector	Directorfiled Oct 13	0	-2

Alerts for Gilbert Lynn Marks

One alert for each Form 4 they file.

Set an alert

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Here is what Pro members see.

Insider trades, sorted your way
Every CEO's buy is here, the biggest names first. Filter by role, side, and size, and set optional alerts.
Their trades on the chart
Insider buys and sales marked on the stock's chart, from a year to the full history.
Why a stock ranks
Its Quality Score, its rank, and the reasons behind it, on one card.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
The score, added up
Price action, the company, and signals, each with its points, summed into one number on every stock's page.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

Others who file at AN2 Therapeutics

Insider trades by person